ENTITY

Reyon Pharmaceutical (102460 KS)

7
Analysis
Health Care • South Korea
Reyon Pharmaceutical Co., Ltd. produces over the count drug and raw materials for drug. The products include antibiotics, antiphlogistic, and generic drugs.
more
bearish•Quantitative Analysis
•03 Dec 2025 07:00

KRX Short Interest Weekly (Nov 28th): Hanwha Ocean, SK Hynix, Kakaopay, NAVER

We analyzed KRX short interest report for the past week and highlighted short interest changes in Hanwha Ocean, SK Hynix, kakaopay, NAVER, HD...

Logo
204 Views
Share
bullish•Kum Yang
•14 Feb 2023 10:53

KOSPI Size Indices - Potential Changes in March

The review period for the March rebal of the KOSPI Size Indices ends on 28 February. We see quite a lot of potential migrations. Some stocks could...

Logo
565 Views
Share
bullish•Eubiologics
•13 Jan 2017 00:29

Eubiologics IPO Part 3 - IPO Bookbuilding Results & Personal View

Eubiologics IPO price was set at ₩6,000, the lowest end of the indicative price band, after conducting the demand survey (bookbuilding) (Jan 9-10)...

Logo
582 Views
Share
bullish•Eubiologics
•10 Jan 2017 16:02

Eubiologics IPO Part 2 - Growth Potential & Appropriate Valuation Level

* In Part 2 (as below), I examined the company's business fundamentals in more detail along with its growth potential and appropriate valuation...

Logo
325 Views
Share
bullish•Eubiologics
•08 Jan 2017 02:20

Eubiologics IPO Part 1 - Schedule, Financials & Valuation

Eubiologics is a very "young" vaccine company that develops an oral cholera vaccine product called "Euvichol". This company will be Korea's first...

Logo
487 Views
Share
x